详情页 - 首都医科大学附属北京同仁医院知识库

资源类型：

文章类型：

作者：

Gao, Ming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] * ; Chi, Yihebali[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Tang, Pingzhang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Xu, Zhengang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zheng, Xiangqian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Li, Dapeng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Chen, Xiaohong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Ge, Minghua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhang, Yuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Guo, Zhuming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Wang, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Chen, Jie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhang, Jiewu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Cheng, Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Li, Zhendong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liu, Hui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Qin, Jianwu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhu, Jingqiang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Cheng, Ruochuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ;

机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China [3]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [4]Chinese Acad Sci, Zhejiang Prov Peoples Hosp, Peoples Hosp,Hangzhou Med Coll,Zhejiang Canc Hosp, Inst Canc & Basic Med ICBM,Canc Hosp,Univ Chinese, Hangzhou, Peoples R China [5]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Canc Hosp, Nanjing, Peoples R China [6]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [7]Gansu Prov Canc Hosp, Lanzhou, Peoples R China [8]Hunan Canc Hosp, Changsha, Peoples R China [9]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [10]Jilin Canc Hosp, Changchun, Peoples R China [11]China Med Univ, Tumor Hosp, Liaoning Tumor Hosp & Inst, Shenyang, Peoples R China [12]Fujian Canc Hosp, Fuzhou, Peoples R China [13]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China [14]Henan Canc Hosp, Zhengzhou, Peoples R China [15]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [16]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2018]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China [3]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [4]Chinese Acad Sci, Zhejiang Prov Peoples Hosp, Peoples Hosp,Hangzhou Med Coll,Zhejiang Canc Hosp, Inst Canc & Basic Med ICBM,Canc Hosp,Univ Chinese, Hangzhou, Peoples R China [5]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Canc Hosp, Nanjing, Peoples R China [6]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [7]Gansu Prov Canc Hosp, Lanzhou, Peoples R China [8]Hunan Canc Hosp, Changsha, Peoples R China [9]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [10]Jilin Canc Hosp, Changchun, Peoples R China [11]China Med Univ, Tumor Hosp, Liaoning Tumor Hosp & Inst, Shenyang, Peoples R China [12]Fujian Canc Hosp, Fuzhou, Peoples R China [13]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China [14]Henan Canc Hosp, Zhengzhou, Peoples R China [15]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [16]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An analysis based on the ALTER01031 trial

文献详情